hypertension

Sky Labs publish findings on cuffless blood pressure measurement technology
Clinical Trials Arena
Wed, 06/28/23 - 10:29 pm
Sky Labs
South Korea
Medtech
hypertension
cuffless blood pressure measurement
Mineralys reports positive data from trial of lorundrostat for hypertension
Clinical Trials Arena
Mon, 03/6/23 - 10:49 am
Mineralys Therapeutics
clinical trials
hypertension
lorundrostat
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
Endpoints
Mon, 02/13/23 - 10:01 pm
Sun Pharma
generics
product recalls
Diltiazem
hypertension
IPO Doors Creak Open as Mineralys Seeks $192M
BioSpace
Fri, 02/10/23 - 10:31 am
IPOs
Mineralys Therapeutics
hypertension
MLS-101
Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension
Fierce Biotech
Thu, 01/19/23 - 09:59 am
IPOs
Mineralys
hypertension
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Thu, 01/5/23 - 09:57 am
Novartis
generics
antitrust
legal
Exforge
hypertension
CinCor shares dive after blood pressure drug fails key trial
BioPharma Dive
Mon, 11/28/22 - 07:36 pm
CinCor Pharma
clinical trials
hypertension
baxdrostat
Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data
Endpoints
Thu, 11/17/22 - 11:52 am
Mineralys
funding
MLS-101
hypertension
J&J, Idorsia plan filings for aprocitentan data in resistant hypertension
Pharmaphorum
Tue, 11/8/22 - 10:33 pm
JNJ
Idorsia
aprocitentan
hypertension
resistant hypertension
Orchestra BioMed stays on key in extended study of blood pressure reducing device
Fierce Biotech
Wed, 09/21/22 - 10:31 am
Medtech
devices
Orchestra BioMed
hypertension
TCT
pacemakers
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Bristol Myers Squibb
Novartis
Merck
Alnylam Pharmaceuticals
Amgen
hypertension
cholesterol
SoniVie receives FDA approval for Pilot study to treat Hypertension with Renal Artery Denervation TIVUS technology
Drugs.com
Mon, 06/20/22 - 10:47 am
SoniVie
hypertension
FDA
devices
Medtech
TIVUS
J&J's $230M blood pressure bet hits phase 3 endpoint, but questions linger about blockbuster potential
Fierce Biotech
Mon, 05/23/22 - 10:19 am
JNJ
hypertension
Idorsia
clinical trials
aprocitentan
Pfizer's blood pressure med recall creeps into US as testing flags carcinogen threat
Fierce Pharma
Mon, 04/25/22 - 10:23 am
Pfizer
hypertension
product recalls
Accupril
Medtronic posts positive 3-year data in renal denervation ahead of key pivotal readout
Medtech Dive
Tue, 04/5/22 - 11:51 am
devices
Medtech
Medtronic
renal denervation
Symplicity Spyral
hypertension
clinical trials
Pfizer pulls blood pressure medicines in US over cancer-causing impurities
Fierce Pharma
Tue, 03/22/22 - 11:21 pm
Pfizer
hypertension
product recalls
Accuretic
Medtronic misses bid for early FDA OK in renal denervation, stock slides
Medtech Dive
Mon, 10/18/21 - 11:05 am
devices
Medtech
Medtronic
FDA
renal denervation
clinical trials
hypertension
CinCor Raises $143 Million To Fund Innovation in Hypertension Research
BioSpace
Wed, 10/13/21 - 10:36 pm
CinCor Pharma
funding
hypertension
chronic kidney disease
Quiet CinCor Pharma makes some noise with $143M, new trial plans for blood pressure drug
Endpoints
Tue, 10/12/21 - 11:10 am
CinCor Pharma
clinical trials
funding
hypertension
CIN-107
Sanofi, eyeing impurity concerns, pulls hypertension meds in Korea and the UK. Could the next big 'sartan' recall be on the horizon?
Fierce Pharma
Tue, 08/10/21 - 10:39 am
Sanofi
Korea
UK
hypertension

Pages